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Introduction 
Despite a 45% reduction in maternal deaths over the past two decades, about 800 women still die daily 
from pregnancy-related complications that are largely preventable, with 99% of these deaths occurring in 
low- and middle-income countries (World Health Organization, 2015). In Nigeria, as in many developing 
countries, pre-eclampsia and eclampsia (PE/E), and postpartum hemorrhage (PPH) account for about 50% 
of maternal deaths. A recent maternal death and near-miss surveillance in Nigeria confirmed this fact, with 
new findings indicating that PE/E is now the leading direct cause of maternal mortality in health facilities. 
In this study (Oladapo et al. 2015), PE/E and PPH accounted for 23.4% and 14.4% of severe maternal 
outcomes (SMOs), respectively.  
 
Through the Ending Eclampsia project, with support from USAID, Population Council is seeking to expand 
access to proven, underutilized interventions and commodities for the prevention, early detection, and 
treatment of PE/E and strengthen global partnerships. In order to appreciate the enormity of the problem 
at country level, the Council conducted a landscape analysis on PE/E in Nigeria between April and 
September 2015. The main objectives of the landscape analysis were: 
 
• To understand the level of programmatic and policy support for PE/E prevention and treatment; 
• To analyze the gaps in providers’ competence to prevent, detect, and manage PE/E; 
• To determine the capacity at primary health facilities to manage PE/E; 
• To assess community awareness, beliefs, and experiences around PE/E; 
• To understand the volume of research conducted on PE/E in the last 15 years; and 
• To determine priority areas for research and programmatic interventions around PE/E. 
 
In summary, the Council collected data on information around policy support for PE/E, the current program 
elements addressing PE/E in the country, the capacity of antenatal and maternity care facilities to detect 
and manage PE/E, the availability of essential tools and lives-saving commodities at health facilities, the 
communities’ beliefs and misperceptions that hinder pregnant women from receiving timely care, and 
research gaps to improve health care related to prevention and management of PE/E. This report provides 
major highlights of the landscape analysis in Nigeria and suggests priority areas for interventions. The report 
is presented in three thematic areas: policy, health system, and community level. 
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Methodology 
The study was cross sectional and encompasses a systematic review of existing grey and published 
literature, and primary data collection from a range of actors using both qualitative and quantitative 
methods. For the systematic review, researchers analyzed all published literature on PE/E from 2000 to 
2015. For policy and program data at national and state levels, researchers interviewed representatives of 
policy makers, managers of maternal and newborn health programs, and heads of local and international 
NGOs. Health facilities in each state were selected from all three senatorial zones. At each study facility, 
the Council interviewed providers who worked in antenatal, maternity, or labor/delivery wards. Researchers 
also conducted facility inventories and observed client–provider interactions of ANC consultations prior to 
interviewing the same pregnant women leaving the facility. Women (18–49 years) and men (18–55 years) 
participated in focus group discussions (FGDs) to provide a deeper understanding of knowledge and 
perceptions of PE/E and health-seeking pathways of the local community members regarding obstetric 
complications. Researchers interviewed women who had experienced PE/E, as well as family members of 
women who experienced PE/E. The data collection activities fall under three broad categories:  
 
Policy level 
1. Desk review of published and unpublished documents from 2000 to 2015;  
2. In-depth interviews (IDIs) with policymakers, development partners and Ob/Gyns; and  
3. E-Survey of reproductive health program managers in the country. 
 
Health system level  
4. Observations of provider-client interaction during ANC consultations; 
5. Client exit interviews at antenatal clinics (after the consultation) 
6. Facility inventory; and 
7. A self-administered, semi-structured questionnaire for health care providers. 
 
Community level  
8. Focus group discussions with married men and married women; and 
9. Case studies of PE/E survivors.  
 
The study took place in six USAID-supported states―Sokoto, Bauchi, Kogi, Cross River, Ebonyi, and 
Ondo―covering the six geo-political zones in Nigeria. With further support from MacArthur Foundation, a 
similar exercise took place in Katsina State, making a total of seven research states (see map below), in 
addition to  national level information. This study protocol was reviewed and approved by the Population 
Council IRB in New York, with additional reviews and approvals by the National Health Research Ethics 
Committee (NHREC) of the Federal Ministry of Health (FMoH) and the ethics committees of all the 
participating states. All participants gave their informed consent prior to interview.  
 
Before the study commenced, the Council’s research team visited the Federal Ministry of Health (FMoH) 
and the health authorities of all participating states in order to obtain administrative approval for the study 
and stakeholders’ buy-in. The research team, in collaboration with state ministries of health, obtained the 
sample of health facilities to be included in each state and surrounding communities.  
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All questionnaires were retrieved from the field and immediately transferred to Population Council in 
Abuja for data entry and analysis. Researchers analyzed data using SPSS software and results were 
expressed as frequencies and percentages. For the qualitative data, interviews were recorded using 
hand-written notes, supported by tape recordings. These were then transcribed for content analysis.  
 
FIGURE 1   Map of Nigeria showing the states visited for the study 
 
 
 
TABLE 1    Summary of quantitative and qualitative data  
 Bauchi Cross 
River 
Ebonyi Katsina* Kogi Ondo Sokoto Abuja Total 
Type of Data Collection 
Policy 
State IDIs 10 10 10 10 9 10 10  69 
National IDIs        3 3 
Health System 
Client-provider 
observations 
28 15 10 9 15 22 37  136 
ANC Exit interviews 28 15 10 9 15 22 37  136 
Provider interviews 55 59 46 55 44 59 61  379 
Facility inventory 14 11 20 21 8 11 11  96 
Community 
Women IDIs 5 5 5 5 5 5 5  35 
Community IDIs 4 4 4 4 4 4 4  28 
Case studies with 
families 
2 2 2 2 2 2 2  14 
*Activities supported by MacArthur Foundation 
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STUDY PARTICIPANTS’ CHARACTERISTICS/DEMOGRAPHICS 
Table 2 outlines the characteristics of 1) health care providers, and 2) pregnant women observed and 
interviewed at health facilities. 
1. The health care providers (n=379) were interviewed at the facility level who worked in antenatal or 
maternity units. The majority of providers worked in primary or secondary facilities, while 21% work 
in tertiary facilities. Less than 10% of providers interviewed were medical officers; the rest were 
mid-level providers. A quarter of providers had been working in the units for one year or less. 
2. Pregnant women interviewed were those who attended the surveyed facilities for antenatal care. 
They were observed during the consultation with the provider (client–provider interaction or CPI) 
and subsequently interviewed before they left the facility (client exit interview). Most of the women 
surveyed were married, and very few were younger than 19 years. Around one-fifth had no 
education, but 70% reported they completed secondary or tertiary education. More than one-third 
was of low socio-economic status (SES), around half were of middle SES and 16.3% were of high 
SES. In comparison, findings from the most recent Nigerian Demographic Health Survey (2013) for 
the wealth distribution of women of reproductive age surveyed in the country are: Low-37.4%; 
Middle-19.2% and High-43.4%. 
 
TABLE 2   Characteristics of health providers and pregnant women interviewed 
 
 
  
Health providers working in maternal health  Pregnant women attending ANC 
Variable n %  Variable  n % 
Sex    Marital status    
Male 56 14.8  Married/Cohabiting  130 96.3 
Female 323 85.2  Formerly married  5 3.7 
Age    Age   
<20 5 1.3  15-19 6 4.4 
20-29 83 21.9  20-24 35 25.9 
30-39 111 29.3  ≥25 93 68.9 
40-49 89 23.5  No response 1 0.7 
50-59 70 18.5  Facility type   
No response 21 5.5  Tertiary  28 20.7 
Facility type    Secondary  69 51.1 
Tertiary  80 21.1  Primary  38 28.1 
Secondary  124 32.7  Formal education    
Primary  175 46.2  None  29 21.5 
Type of Provider    Primary  12 8.9 
Medical practitioner  35 9.2  Secondary  41 30.4 
Nurse/Midwife 200 52.8  Tertiary   53 39.2 
CHEW, CHO & Others  144 38.0  Religion    
Length of time in unit    Christians 60 44.4 
<=1yr 93 24.5  Muslims  75 55.6 
>1-5rys 158 41.7  Socio-economic status   
>5yrs 89 23.5  Low  50 37.0 
No response 39 10.3  Middle  63 46.7 
    High  22 16.3 
Total  379 100.0  Total  135 100.0 
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Results 
SYSTEMATIC REVIEW OF PUBLISHED PAPERS ON PE/E  
The research team developed two sets of key terms related to pre-eclampsia and eclampsia that captured 
citations for peer-reviewed papers related to detection, management, and prevention of PE/E. The first 
search was designed to capture results that do not mention PE/E explicitly and the second search included 
the MeSH (medical subject headings) terms for PE/E and the rare complication known as, HELLP syndrome. 
This is H (hemolysis, the breaking down of red blood cells) EL (elevated liver enzymes) LP (low platelet 
count). The two searches were run in bibliographic databases including: ScienceDirect PubMed, World of 
Science, Cochrane, POPLINE, and Wiley Online Library. These searches used a combination of terms linking 
various aspects of the diagnosis, treatment, and prevention of pre-eclampsia, eclampsia and hypertensive 
disorders of pregnancy. Searches were limited to articles published from 2000 to 2015 (April). After 
removing duplicate citations and those that were obviously unrelated to this review, the initial database 
searches identified 520 abstracts, which were included in Phase I review. Two reviewers removed 338 
articles that did not fulfill the inclusion requirements for Phase I. During Phase II, 30 articles were removed 
because they were written about data collected before 2005 and were mainly related to comparing 
magnesium sulphate and diazepam. A total of 133 articles were included in the systematic review (full 
report separate). 
 
FIGURE 2   Flow diagram of systematic review methods and results 
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INTERVENTIONS TO REDUCE MATERNAL MORTALITY DUE TO PE/E 
From the articles reviewed, it was clear that the following factors contribute to high maternal morbidity and 
mortality due to pre-eclampsia and eclampsia: substandard care due to under staffing or un-skilled birth 
attendants, lack of knowledge on correct use of MgSO4, inadequate antenatal care services, poor attitudes 
towards clients, and delays in patient care.  
 
Twenty one intervention articles were identified from the researched literature that relate to best practices 
for detecting, preventing and managing PE/E. Most of the papers focused on studies confirming the dosage 
regimens and training of clinical providers on the use of MgSO4 as a safe and effective method to treat 
women with eclampsia in Nigeria and globally. Of these, eight articles were identified as best practice 
models developed specifically to address the gaps and challenges in the management and treatment of 
PE/E in Nigeria. These interventions were categorized into three main areas for addressing PE/E:  
 
1) Training and re-training of healthcare providers on administering magnesium sulphate 
2) Task shifting to increase access to services in primary health care facilities and rural areas  
3) Quality of care and protocol development for the management of pre-eclampsia and eclampsia. 
 
In order to improve the quality of care, efforts have been made to develop protocols to train and re-train 
healthcare providers to screen pregnant mothers during ANC visits and detect signs of pre-eclampsia, as 
well as administer MgSO4 to patients requiring anticonvulsant therapy. In addition, tools and strategies to 
ensure standardized services and consistent provider efficacy have been developed based on the local 
context. 
 
Training and re-training of healthcare providers on administering MgSO4 
 
Although, the role of MgS04 in reduction of maternal death from eclampsia is well established, its use 
remains low in many resource poor countries like Nigeria due to lack of availability and inconsistent 
knowledge and guidelines on its use. There is a need for simplified guidelines that can be adapted 
contextually to train and re-train doctors, nurses, midwives, and other healthcare providers on the correct 
dosage and monitoring for toxicity.  
 
Three pre and post intervention study designs focused on developing evidence-based protocols for training 
and re-training healthcare providers on correctly administering the MgSO4 dosage using the “Pritchard 
regimen.” All three studies showed a significant reduction (approximately 80%) in the case fatality rate due 
to pre-eclampsia and eclampsia (Ezugwu et al. 2014; Okonofua and Ogu 2013; Tukur, Ahonsi, and Ishaku 
2013). 
 
Task sharing to increase access and availability of services for PE/E 
 
The utilization of MgSO4 in Nigeria is mostly restricted to secondary and tertiary levels with presumed 
human and technical capacity to administer and monitor the safety and toxicity of the drugs. A study 
conducted by Ishaku et al. (2013) showed that task shifting and/or task sharing mechanisms to community 
health officers (CHOs) and community health extension workers (CHEWs) enabled them to successfully 
administer MgSO4 in primary healthcare settings. However, the study also indicated that pregnant women 
who sought services from the CHEWs and CHOs did not always follow-up for further treatment. There was a 
90% default rate with referrals – leading researchers to believe that due to the instant relief felt after the 
administration of the MgSO4 loading dose women and their families may have assumed the treatment was 
complete and that no further referral was necessary. However, demographic factors indicated that these 
women were mostly illiterate and the majority were younger than 20 years, which could also play a role in 
poor adherence to treatment. Adequate counseling and appropriate community mobilization and 
community-level action are needed to increase adherence for clients to complete their treatment of PE/E. 
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Quality of Care and Protocol Development for the management of PE/E 
 
In order to address the issues around quality of care and better protocol adherence, Ameh et al. (2012) 
designed the ‘LIVKAN Chart’ based on feedback from 118 skilled birth attendants (SBAs). The LIVKAN Chart 
is a two-page algorithm that lays out key questions and regimens for the treatment and management of 
PE/E. This chart is easy to use and has potential to maintain a standardized quality of care across different 
cadres of health providers and helps to reduce the missed opportunities for treatment of PE/E cases in low 
resource settings. Of the SBAs who used the chart, 98% thought it was useful and 73% of respondents said 
that lower level healthcare workers could provide better quality of care and good quality documentation for 
referrals if they used the chart. 
 
A retrospective and comparative study of maternal deaths was conducted between 2004 and 2010 
(Igwegbe et al., 2012) to evaluate the impact of the introduction of the Service Compact with all Nigerians 
(SERVICOM) contract on maternal health at Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria. 
The main outcome measures were yearly maternal mortality ratio (MMR), relative risk (RR) of maternal 
mortality, and presentation-intervention interval. The yearly MMR and the RR of maternal mortality were 
compared with the figures from 2004, which represented the pre-SERVICOM era. The SERVICOM charter 
was developed by the Federal Government of Nigeria to try to address poor health provider attitude—
including lateness-to-work, long patient waiting hours, out-of-pocket expenses, and lack of empathy towards 
clients. SERVICOM “dedicates itself to providing the basic services to which each citizen is entitled in a 
timely, fair, honest, effective and transparent manner.” Under this charter, health providers are mandated 
to provide quality services designed around the requirements of their customers and all clients must be 
served by staff sensitive to their needs; commitment to the provision of services within realistic time frames. 
SERVICOM also provides a waiver for emergency drugs and surgery, and patients were able to pay after 
adequate resuscitation. Igwegbe et al. found that a positive change in the attitude of health workers and 
the elimination of fee-for-service in emergency obstetric care could reduce type three delays in public health 
facilities, and consequently reduce maternal mortality (Igwegbe et al., 2012). 
 
Another case of new protocol development was successfully initiated in Nigeria under the FIGO Saving 
Mothers and Newborns Initiative (2006-2011), which aimed to provide training on integrated emergency, 
obstetric and newborn care (EmONC) to strengthen the capacity of national obstetric and midwifery 
societies to improve EmONC services through protocol development and advocacy activities. Three hundred 
and sixty eight doctors, nurse-midwives were trained in EmONC in three selected hospitals in Edo, 
Amambra, and Kaduna. There was a significant reduction (approximately 28%) in maternal mortality due to 
eclampsia at the project sites. Furthermore, MgSO4 was supplied to all state hospitals in Kaduna State, four 
obstetric protocols were introduced, and manufacturers reduced the cost of MgSO4 (Lalonde and Grellier 
2012).  
 
Another issue is the quality of antenatal care (ANC) services. While the WHO recommends at least four ANC 
visits during the pregnancy, less than 39% of pregnant women seek ANC in Nigeria. In a study conducted 
by Osungbade et al., 2008, the authors found inadequacies in the content of ANC services at the secondary 
healthcare facilities area. The screening services and care only had reasonable capacity to provide 
opportunities for prompt intervention against pre-eclampsia and early detection of some fetal problems. 
Osungbade et al. concluded that it will be necessary to assess the content of ANC packages as a measure 
of quality in line with the WHO guidelines to ensure that women are screened for PE/E. Equipping healthcare 
facilities with capacity to detect high blood pressure and proteinuria is necessary to screen women for pre-
eclampsia and eclampsia (Osungbade 2008).  
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POLICY FORMATION AND IMPLEMENTATION AROUND PE/E IN NIGERIA 
Policymakers appear to understand the enormous burden of PE/E and its consequences on maternal and 
newborn survival, and they know that if PE is detected during ANC visits, eclampsia and other complications 
are avoidable. Many policy makers know how the use of MgSO4 shapes maternal and newborn outcomes 
related to PE/E: 
 
“It is one of the leading causes of maternal death in Ondo state after postpartum 
hemorrhage. The mortality is high. [It] was very difficult to manage before the advent of 
magnesium sulphate.” Policymaker, Ondo State 
 
Almost all stakeholders, with the exception of those from Ebonyi, agreed there is a need to build the capacity 
of primary health care (PHC) providers to detect, manage, and refer PE/E patients.  
 
“At the primary level where, if a case like this is detected, the loading dose of MgSO4 should 
be administered and a quick referral to a tertiary institution should be done. But some of 
the primary facilities we have around here are not well equipped, and the people working 
there are not well trained. So at the end of the day, they might not diagnose and refer 
immediately and sometimes the women present in a bad state. By the time they run around 
and do one or two things, the patient might deteriorate.” Labor ward nurse  
 
Some stakeholders from Ebonyi were against the initial management of PE/E at the PHC level due to 
perceived incompetence of the CHEWs to administer MgSO4 safely, despite local and international evidence 
pointing to the contrary.  
 
“It depends on the capacity of the staff in primary care center because magnesium sulphate 
is not something anybody can administer… we only allow MgSO4 to be administered by 
midwives and registered nurse/midwives.” Policymaker, Ebonyi 
 
Despite the wide-spread availability of international and local guidelines for managing PE/E, few state level 
policymakers were aware of these guidelines. However, those with nursing and midwifery backgrounds were 
more aware of the existence and availability of such documents in their state and even at the facility level. 
Therefore, it appears as though receipt of evolving national policy documents depends on communication 
between the federal and state MOH.  
 
MgSO4 is one of the 13 United Nations Life-Saving Commodities for Women and Children, and is also a 
priority drug for the FMoH, which in 2013 developed a fully-costed implementation plan for MgSO4. 
Specifically, the Ministry planned to procure and distribute 437,160 vials of MgSO4 at an estimated cost of 
$218,580.00 (Federal Ministry of Health, 2013) for public sector distribution and utilization.  
 
“For the past four or five years, government has even brought in magnesium sulphate and 
has also given some baseline training to healthcare providers on how to use it.” Director of 
Medical Services and Training, FMoH 
 
To a large extent, national procurement and distribution of MgSO4 has not been accomplished. Although 
there is a national essential medicines list (EML) and state EMLs (usually based on the national one), it is 
not clear whether and how MgSO4 is procured at national level. A special budget was created for it among 
the 13 UN commodities for life saving drugs for mothers and children, but it is not known how active this is 
as there appears to be no regular MgSO4 procurement and distribution at national or state level. However 
federally-initiated procurement is not the only option in the country, as private sector procurement covers 
most of the gaps and some states procure this commodity (and others) through a separate arrangement in 
an open market. This system is largely ineffective based on the accounts presented by most of the 
policymakers interviewed. MgSO4 is either not budgeted for, or the allocated funds are not spent 
appropriately, and secondary and primary health care facilities experience frequent stock outs.  
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The affordability of MgSO4 for many clients depends on their income, as out-sourcing from private vendors 
is now routine. Consequently, stakeholders raised concerns of quality control for drugs obtained outside 
the hospital. They also expressed fears about the consequences of poor quality drugs for mothers and 
newborns. These fears are worsened by the fact that there is no known local manufacturer in the country, 
although pharmaceutical companies are occasionally involved in distributing the drugs at private outlets. 
 
“I will say that magnesium sulphate is readily available, but it’s not really very affordable for 
a poor man; because for a loading dose, you need to administer three ampules of it and its 
quite expensive for a patient that doesn’t really have much.” Policymaker, Ebonyi 
 
The World Health Organization recommends using prophylactic low-dose aspirin and calcium 
supplementation for prevention of pre-eclampsia in high-risk women, but few policymakers and service 
providers were aware of this, and so the uptake of these preventative practices is low. Policymakers are, 
however, supportive of this policy and would be willing to review their local strategies and plan for policy 
change and implementation within their states once they verify the FMoH’s support of these preventative 
measures.  
 
“The state government policy should be that of the National policy, but right now, I am not 
aware of a policy from the FMoH that is for the routine use of aspirin. I am not aware it is a 
policy now. There might be individual doctors based on their professional experience using 
it, but I am not aware of any policy advocating the use of aspirin as prophylaxis.” 
Policymaker, Ebonyi 
 
There were mixed responses regarding the functionality of the referral system that links community facilities 
to referral facilities for major obstetric emergencies. Inadequate funding, communication and 
transportation difficulties, corruption, and influence of traditional birth attendants (TBAs) are among the 
challenges cited as contributors to the poor referral pathway. Some of the measures suggested to improve 
the referral pathway include grassroots health education, training of TBAs on referral system, community 
sensitization, recruiting replacements for retirees, improved road network, improved communication 
means, and periodic training of healthcare providers. 
 
“Primary healthcare board has midwives in all hospitals. Abiye program has been instituted 
and is running smoothly. Nurses are trained to refer cases to nearest secondary facility 
before they become complicated. Delivery and CS are free in all government and mother 
and child hospitals; hence reducing all delays.” Director of Nursing 
 
Policy stakeholders unanimously agreed on the need for community mobilization activities around PE/E. 
This, they believe, would go a long way in reducing the many problems associated with management of 
PE/E. Suggested strategies for this included the use of a mediating team, community sensitization 
seminars, community engagement workshops, and use of mass media as communications tools.  
 
  
 10 
 
DONOR/PARTNER PROGRAMMATIC SUPPORT FOR MATERNAL AND 
NEWBORN HEALTH IN NIGERIA 
As part of the landscape analysis in Nigeria, we designed an online survey to assess what work related to 
MNH is being implemented by international and national partners. The survey aimed to assess the breadth 
and depth of MNH work, as well as assess the geographic coverage in-country, discover the key funders of 
MNH projects, and explore the primary topic areas that programs target. The survey was targeted at 
representatives of organizations known in Nigeria as well as key international partners; eleven responses 
were captured.  
Current Maternal and Newborn Health Projects 
When asked about the areas of focus for current MNH programs, the most frequently reported topics were 
quality of care (n=8), pre-eclampsia/eclampsia (n=7), ANC (n=6), maternal mortality death review (n=6), 
family planning (n=6), severe bleeding/post-partum hemorrhage (n=6), task-shifting (n=6), and Emergency 
Obstetric and Newborn Care (EmONC) (n=5). These programs are being implemented in 23 of Nigeria’s 36 
states and in Abuja, the Federal Capital Territory. Five respondents reported implementing MNH programs 
in Kano State. The next most commonly reported states with four responses each were Jigawa, Kaduna, 
Lagos, Sokoto and Zamfara.  
 
MNH projects are being implemented across all levels of the health system. Most of the respondents 
reported working at multiple levels: Six reported working in tertiary level hospitals, seven in teaching 
hospitals, ten in secondary level facilities, ten in primary care centers, five work in community clinics, and 
seven said that they work in communities. The organizations implementing these projects reported that 
their work has the most influence related to advocacy (n=8), policy (n=7), and service delivery (n=4).  
Current Funders of Maternal and Newborn Health Projects 
The most often reported funding organizations include: USAID, The John D. and Catherine T. MacArthur 
Foundation, the Bill and Melinda Gates Foundation, and Merck for Mothers Giving Program. The Ford 
Foundation, T.Y. Foundation, WHO, International Development Research Centre (IDRC), and Canada were 
also cited as current donors for MNH programs in Nigeria. 
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National Stakeholders Views on PE/E 
In addition to the above we also asked a range of stakeholders, who attended the dissemination meeting 
in Abuja in August 2015, their opinion on issues related to programing for prevention and treatment of PE/E 
(see Box 1). The stakeholders were from international and national NGOs, state level health managers and 
donors. 
 
BOX 1: Stakeholders’ views  on current issues around PE/E 
Question  Participant Response  
What are the 
bottlenecks at 
system or 
facility level? 
No adequate health policy in place to prevent and treat PE. 
Health System failure: 1) the FMoH is lagging and the 3° and 2° and 1° facilities do 
not have essential medicines equitably provided, especially 2) weak human 
resources e.g. Skilled birth attendants, and 3) literacy is a major bottleneck. 
Delay in obstetric care and decision making to seek care at a facility.  
Delays in referral and treatment, and inadequate drugs. 
Limited supportive supervision and low commitment from the policy makers. 
Poor attitudes of health workers at the facilities.  
Challenges of sustainability, which requires strong advocacy to policy makers.  
Policy makers to consider maternal health issues as a top priority.  
 
What are the 
potential areas 
of synergy? 
Proper coordination of all stakeholders. 
Improved information sharing and communication. Basket funding. 
Liaise with the state/local government in terms of provision of basic amenities.  
Make MgSO4 available at all levels.  
Ensure proper management of health care. 
 
How can 
communities be 
more engaged? 
Educate community about the benefits and importance of ANC and negative effect of 
not attending facility before and after birth through advocacy. 
Involve community leaders and gatekeepers at the table from the onset and 
throughout the program concept/development/implementation.  
Communicate in language(s)/channels that they understand. 
Engage with: women’s groups, traditional leaders, men, and faith-based home/birth 
attendants (including TBAs). 
 
What are 
promising 
practices? 
Early detection of pre-eclampsia and prompt delivery of eclamptic women. 
MgSO4 readily available at the central medical store. 
Increase in ANC attendance.  
Early diagnosis and management to reduce morbidity and mortality. 
TBA referrals for ANC after receiving training.  
CHWs trained to identify PE/E, and to give appropriate stabilizing care before 
referring women. 
 
Other 
challenges and 
gaps? 
Lack of political will and of sustainability of existing successful programs.  
Attitudes of policy makers and health workers.  
Partners working on RMNCH need to pool resources together.  
USAID needs to coordinate the process because there is so much verticalization of 
the same activities.  
No involvement of traditional religious bodies. 
Transportation—bad road to facilities. Access: too hard to reach remote areas. Poor 
network in the community area. 
Traditional beliefs and cultural/religious practices. 
Knowledge and attitude of client.  
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HEALTH SYSTEM LEVEL 
A range of health providers working in ANC, maternity and labor/delivery wards were interviewed, we 
observed provider-client interactions during ANC consultations, conducted a facility inventory assessment, 
and collected a self-administered, semi-structured questionnaire for front-line health care providers. This 
study investigated providers’ knowledge, practice, skills, and experiences in preventing detecting, and 
managing PE/E. For the purpose of this study, the definitions used throughout this study are presented in 
Box 2.  
BOX 2: Definitions  
Pre-eclampsia is the development of hypertension and significant proteinuria for the first time after 
20 weeks of gestation.  
• Hypertension is defined as blood pressure (BP) measurement of ≥140 mmHg systolic 
and/or BP of ≥90 mmHg diastolic measured on two consecutive occasions six hours 
apart.  
• Significant proteinuria is defined as protein of 0.3g in 24 hours collection of urine, or a 
urine protein estimation that is ≥ 2 (++) using dipsticks.  
 
Severe pre-eclampsia is associated with symptoms and clinical manifestations such as severe 
headache, changes in vision (including temporary loss of vision/blurred vision, light sensitivity, 
seeing spots), upper abdominal pain (usually under ribs on the right side, nausea/vomiting, 
dizziness, and decreased urine output.  
 
Eclampsia is defined as the occurrence of chronic convulsions in a pregnant woman with the 
absence of any neurological cause. 
 
Chronic hypertension in pregnancy is defined as a pregnant woman with a BP recording of 
160/100 mmHg with no proteinuria.  
 
 
Knowledge and practice of healthcare providers for the prevention of PE 
Researchers assessed health care providers’ knowledge of proven risk factors for PE, including chronic 
hypertension, obesity, pre-existing diabetes or diabetes in pregnancy, advanced maternal age (≥ 35 years), 
sickle cell diseases, previous history of PE/E, and connective tissue diseases.  
 
The following definitions were used to measure provider awareness for the prevention of eclampsia: 
 
Assessing the risk of PE:
  
    
History of hypertension/high BP, history of diabetes, asked about 
date of  last delivery, client’s weight, checked edema (face, hands, 
legs and ankles), pregnancy order, and client’s age. 
 
Detecting PE: Client’s blood pressure and urinalysis (protein/albumin). 
Advising on symptoms of 
impending eclampsia: 
Severe headache, blurred vision and pre-eclampsia with generalized 
body swelling. 
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Only 15 percent of the providers interviewed (n=379) across the seven states reported that they look for 
risk factors related to PE during ANC consultations (Figure 3).  
 
FIGURE 3   Results from ANC provider-client observations (n=379) 
 
 
 
The study further investigated whether providers were aware of, or ever used, any prophylactic drugs, to 
prevent PE among pregnant women at risk. Overall, only 19 percent (n-79) of providers were aware of 
prophylactic drugs to prevent PE. Out of these 79 providers, 14 percent mentioned aspirin 5% mentioned 
calcium supplements, 58 percent mentioned other drugs (incorrectly) and 23 percent did not know which 
drugs.  This varied widely between states. For example, of the 6 Ebonyi providers who knew that prophylactic 
drugs could be used to prevent PE, two mentioned aspirin, one mentioned calcium and three mentioned 
other drugs.  In Sokoto none of the providers were aware of the prophylactic use of aspirin and calcium. 
Moreover, some of the providers appeared to be confused regarding indications for these drugs during 
pregnancy.  
 
The providers who did not know of aspirin or calcium prophylaxis for PE prevention (58%) but mentioned 
other drugs listed aldomet, hydralazine, or nifedipine (which are used to lower blood pressure) and 
phenobarbitone, and diazepam (which were previously used for managing convulsions). This shows that 
many providers do not understand the difference between prophylaxis and treatment. 
 
The medical practitioners―obstetricians and gynecologists (15% of providers interviewed) ―were more 
likely to use aspirin prophylaxis for high-risk women and use anti-hypertensives in pregnant women with 
high blood pressure. Those with more years of experience of working in a maternity unit gave aspirin 
prophylaxis, but there was no difference in experience for those prescribing anti-hypertensives. Previous 
exposure to training in maternal and child health (MCH) had a positive effect on the provision of aspirin 
prophylaxis and anti-hypertensives. Table 3 shows the use of aspirin prophylaxis and anti-hypertensives by 
provider type, facility level experience and training. 
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TABLE 3    Use of Aspirin and Anti-hypertensive drugs for women who are at risk of 
developing PE/E 
 Use aspirin among women who are at risk 
of developing PE 
Use anti-hypertensive drugs for pregnant 
women who have high BP 
 % Correct 
response 
p-value n=379 
% Correct 
response 
p-value N=379 
Type of provider        
Medical practitioners  22.9 
0.000 
35 65.7 
0.000 
35 
Nurses/Midwives  11.5 200 48.5 200 
CHEWs, CHOs & Others  2.8 144 31.9 144 
Type of facility        
Tertiary  8.8 
0.003 
80 51.3 
0.076 
80 
Secondary  16.1 124 47.6 124 
Primary  4.6 175 37.7 175 
Years working in present unit/ward      
≤1 years  8.6 
0.895 
93 49.5 
0.334 
93 
>1—5 years  8.9 158 41.8 158 
>5 years  11.2 89 46.1 89 
No response  7.7 39 33.3 39 
Received any training on maternal health, FP or child health care   
Yes  12.9 
0.012 
194 49.5 
0.022 
194 
No  5.4 185 37.8 185 
 
The capacities of healthcare providers to detect hypertensive disorders in 
pregnancy 
Healthcare providers were asked a number of questions relating to hypertensive disorders in pregnancy. 
Overall, less than half (48.5%) of all providers could identify chronic hypertension in pregnancy when 
responding to a hypothetical case study about a 12-week pregnant woman presenting for ANC with a blood 
pressure recording of 160/100 mmHg with no proteinuria. The proportions of providers who could correctly 
identify chronic hypertension in pregnancy for each state are Bauchi=34.5%, Cross River=50.8%, 
Ebonyi=52.2%, Katsina=40.0%, Kogi=43.2%, Ondo=61.0%, and Sokoto=55.7%. 
 
The majority of providers were able to identify the signs and symptoms of pre-eclampsia (64%) and 
eclampsia (81%), with some range between states (Figure 4). Few providers could identify severe PE using 
symptoms other than severe hypertension and significant proteinuria. The diagnosis of severe PE is an 
important landmark in decision-making in PE management and eclampsia prevention.  
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FIGURE 4 What are the signs/symptoms of pre-eclampsia, severe pre-eclampsia and 
eclampsia? 
 
 
 
The knowledge and ability of providers to detect and classify hypertensive disorders in pregnancy were 
further analyzed against independent variables: the cadres of health providers, types of facilities, length of 
time they worked in their respective facilities, and whether they received MCH training (Table 4). Health 
providers with more training are better able to correctly classify severe PE, chronic hypertension in 
pregnancy, and eclampsia. However, there is no direct correlation between correct clinical classification 
with facility type, years of service, or previous exposure to MCH training. 
 
TABLE 4    Provider knowledge to diagnose chronic hypertension, SPE and E 
 A pregnant woman presents 
at 12 weeks with BP 
160/100mmHg with no 
proteinuria (Chronic 
hypertension in pregnancy)  
A pregnant woman presents at 
ANC at 30 weeks with BP of 
180/115mmHg and proteinuria 
of 2++  (Severe pre-eclampsia)  
A pregnant woman developed 
hypertension and significant 
proteinuria at 30 weeks. 
Brought back a week later with 
convulsions (Eclampsia) 
 % Correct 
diagnosis 
p-
value 
N=379 
% Correct 
diagnosis 
p-value N=379 
% Correct 
diagnosis 
p-
value 
N=37
9 
Type of provider           
Medical practitioner 82.9 
0.000 
35 85.7 
0.000 
35 94.3 
0.000 
35 
Nurse/Midwife 52.5 200 79.5 200 83.0 200 
CHEW/CHO/ Others 34.7 144 61.8 144 61.1 144 
Type of facility          
Tertiary 56.3 
0.000 
80 76.3 
0.001 
80 83.8 
0.000 
80 
Secondary 59.7 124 83.9 124 86.3 124 
Primary 37.1 175 64.6 175 64.6 175 
Years working in present unit/ward  
≤1 years 60.2 
0.071 
93 71.0 
0.820 
93 80.6 
0.043 
93 
>1—5 years 43.7 158 74.7 158 72.8 158 
>5 years 44.9 89 75.3 89 82.0 89 
No response 48.7 39 69.2 39 61.5 39 
Received any training on maternal health, FP or child health care  
Yes 49.0 
0.867 
194 74.2 
0.693 
194 78.9 
0.144 
194 
No 48.1 185 72.4 185 72.4 185 
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The capacity of health facilities and service providers to manage pre-eclampsia 
and associated morbidities 
Health facilities must be equipped with relevant life-saving commodities, equipment and drugs. To detect 
PE/E during ANC visits, facilities must have sphygmomanometers and stethoscopes to measure blood 
pressure and urine dipsticks to enable rapid assessment of urine sample for significant proteinuria. During 
this landscape analysis, 96 facilities were assessed in the seven states. Table 5 presents the proportion of 
facilities that were equipped with specific ANC commodities and equipment to detect PE. Availability of 
dipsticks to test for proteinuria and urine collection containers is low overall but more so at secondary and 
tertiary levels. Primary level facilities are less likely to have functioning stethoscopes and 
sphygmomanometers. 
 
TABLE 5    Proportion of facilities that have the key ANC equipment to detect pre-
eclampsia  
State  
Are there 
functioning 
stethoscopes? 
Are there functioning 
Sphygmomanometers? 
Are there dipsticks 
for testing protein in 
urine? 
Do you have clean 
containers for urine 
collection? 
Total Number 
of facilities 
visited 
 Yes (%) Yes (%) Yes (%) Yes (%)  
Cross River  72 82 46 46 11 
Ebonyi  65 50 55 50 20 
Ondo  64 73 27 46 11 
Kogi  87 88 25 50 8 
Sokoto  91 91 45 55 11 
Katsina  86 79 50 64 14 
Bauchi  81 76 57 81 21 
Total  77 74 47 58 96 
Availability by level of facility 
 Yes (%) Yes (%) Yes (%) Yes (%)  
Tertiary  90 100 40 60 10 
Secondary  82 85 37 48 27 
Primary  73 64 53 63 59 
Total  77 74 47 58 96 
 
 
Figure 5 shows that less than one-third (31%) of facilities had all the necessary equipment and supplies, 
and a little more than one-third (34%) had MgSO4 available in the labor and maternity units when the 
researchers visited. Less than one-fifth of facilities had the correct guidelines in place for managing PE/E, 
including for the administration of MgSO4. When researchers visited the facilities in Sokoto, no facilities 
had protocols or guidelines in place, only 9 percent stocked MgSO4 and 18 percent had the essential tools 
and equipment. 
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FIGURE 5 Availability of guidelines for management of PE/E, ANC equipment to detect 
pre-eclampsia and manage PE/E using MgSO4 
 
 
Table 6 outlines the proportion of facilities that have the key drugs, equipment and supplies to treat PE/E 
and monitor for MgSO4 toxicity. Majority of facilities to do not have patella hammers or urine catheters 
and bags to measure urine output. More facilities are using MgO4 than have the correct antidote (calcium 
gluconate).  
 
TABLE 6    Proportion of facilities that have the key drugs and equipment to manage 
SPE/E and observe for MgSO4 toxicity  
State  
Anti-
hypertensives  
MgSO4  
 
Patella  
Hammer 
 
Urine 
Catheter  
 
Urine bag 
 
Calcium  
Gluconate 
 
Total 
Number 
of 
facilities  
 Yes (%) Yes (%) Yes (%) Yes (%) Yes (%) Yes (%)  
Cross River  0 46 0 46 36 20 11 
Ebonyi  5 25 5 45 15 0 20 
Ondo  55 55 18 64 64 43 11 
Kogi  38 25 13 71 57 0 8 
Sokoto  9 9 9 64 64 13 11 
Katsina  0 43 36 57 57 30 14 
Bauchi  10 38 10 57 43 6 21 
Total  14 34 13 56 44 15 96 
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Figure 6 demonstrates the other critical commodities and equipment required in the maternity/labor ward 
to manage complications.  
FIGURE 6 Proportion of all facilities with emergency equipment, supplies and drugs for 
EmONC 
 
*6mg bethamethasone and dexamethasone (corticosteroids) 
 
Providers must possess the knowledge and skills to manage PE/E appropriately. Specifically, in 
hypertensive disorders during pregnancy, providers must know how to manage hypertension using the 
recommended anti-hypertensives at the right time. They must also know how to administer anticonvulsants, 
such as MgSO4 and calcium gluconate, if required.  
 
In this study, researchers asked healthcare providers about commonly used anti-hypertensives for 
managing mild to moderate hypertension in pregnancy. Most guidelines first recommend labetalol, and 
nifedipine or aldomet as suitable alternatives (UK National Institute for Health and Care Excellence, 2010). 
As labetalol is not widely available in Nigeria, nifedipine and aldomet are often the drugs of choice. Only 
41percent of health providers mentioned aldomet or nifedipine as drugs of choice for managing mild to 
moderate hypertension in pregnancy. In all states, with the exception of Ondo, less than half of providers 
gave the correct responses (Bauchi=42%, Cross River=36%, Ebonyi=28%, Katsina=49%, Kogi=46%, 
Ondo=53%, and Sokoto=33%).  
 
Standard practice recommends initiating anti-hypertensives in pregnant women with mild to moderate 
hypertension at blood pressure level of ≥150/100 mmHg (UK - National Institute for Health and Care 
Excellence, 2010). When blood pressure is ≥ 160/110 mmHg, the use of vasodilators to rapidly lower the 
blood pressure to a safer level (diastolic <110 mmHg) is also recommended. Only 2 percent of providers 
knew when to introduce anti-hypertensive drugs in women with mild to moderate hypertension. Table 6 
shows poor provider knowledge for introducing anti-hypertensives in pregnant women with hypertensive 
disorders, such as PE. There is no correlation between the type of facility and which providers know when 
to start anti-hypertensives. Knowledge gaps persisted across providers at primary, secondary, or tertiary 
facilities.  
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TABLE 7    Knowledge of BP measurement when anti-hypertensives are introduced for 
moderate and severe hypertension 
 Mild to moderate hypertension Severe hypertension 
 
% Correct response p-value 
n= 
379 
% Correct response p-value 
n= 
379 
Type of provider        
Medical practitioner  2.9 
0.323 
35 5.7 
0.071 
35 
Nurse/Midwife  3.0 200 5.0 200 
CHEW. CHO & 
Others  
0.7 144 0.7 144 
Type of facility        
Tertiary  2.5 
0.118 
80 2.5 
0.015 
80 
Secondary  4.0 124 7.3 124 
Primary  0.6 175 1.1 175 
Years working in present unit/ward     
≤1 years  1.1 
0.617 
93 1.1 
0.359 
93 
>1—5 years  3.2 158 3.2 158 
>5 years  1.1 89 5.6 89 
No response  2.6 39 5.1 39 
Received any training on maternal health, FP or child health care 
Yes  0.5 
0.033* 
194 3.6 
0.845 
194 
No  3.8 185 3.2 185 
 
A crucial component of managing PE/E is the use of anticonvulsants. Evidence recommends MgSO4 as the 
‘gold standard’ for preventing and treating convulsions in severe PE/E. Administering MgSO4 
intramuscularly (Pritchard regimen1) is preferred and is the most utilized regimen. In this regimen, a dose 
of 14 grams of MgSO4 is administered as the loading dose, followed by five grams intramuscularly into 
alternate buttocks every four hours for maintenance. Only 12 percent and 10 percent of health care 
providers knew the correct loading and maintenance doses of MgSO4, respectively. Figure 7 shows the 
proportion of health providers, who knew the correct amount used in a loading dose.  
 
FIGURE 7    Correct knowledge of loading dose of MgSO4 for PE/E (Pritchard regimen) 
 
                                                                          
 
 
1 The alternative regimen is the Zuspan regimen where MgSO4 is administered intravenously at a given rate using an infusion 
pump. Because infusion pumps are generally not available in most developing countries, Nigeria adopted the Pritchard regimen 
for all of levels of health care services. 
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Table 8 indicates the knowledge of loading and maintenance doses of MgSO4 among the health providers 
in respect to their medical qualifications, years of experience, type of facility, and whether they received 
prior MCH training. Although overall knowledge is low significantly more medical practitioners knew the 
loading dose (compared to other lower level cadres), but more nurse/midwives knew the maintenance 
dose. Significant differences were also noted at level of facility where significantly more providers at 
secondary level facilities knew the loading dose, yet tertiary level providers knew the maintenance dose.  
 
TABLE 8    Knowledge of total loading and maintenance doses of MgSO4 
 What is the total loading  
dose of MgSO4? 
 What is the maintenance dose of 
MgSO4 in PE/E for intramuscular 
injection? 
 
 % Correct 
response 
p-value n=379 % Correct response p-value n=379 
Type of provider        
Medical practitioners  25.7 
0.000 
35 8.6 
0.000 
35 
Nurses/Midwives 14.5 200 16.0 200 
CHEWs, CHOs & Others  4.2 144 2.8 144 
Type of facility        
Tertiary  12.5 
0.000 
80 25.0 
0.000 
80 
Secondary  21.0 124 9.7 124 
Primary  4.6 175 4.0 175 
Years working in present unit/ward 
≤1 years  11.8 
0.560 
93 10.8 
0.377 
93 
>1—5 years  10.8 158 12.0 158 
>5 years  14.6 89 10.1 89 
No response  7.7 39 2.6 39 
Received any training on maternal health, FP or child health care 
Yes  11.3 
0.049 
194 11.3 
0.113 
194 
No  11.9 185 9.2 185 
 
Although MgSO4 toxicity is rare, when it occurs, the universal antidote is calcium gluconate. Only 7 percent 
of the providers knew to use calcium gluconate as the antidote for MgSO4 toxicity (Figure 8). Almost two-
thirds of providers did not know an antidote exists.  
 
FIGURE 8   Knowledge of calcium gluconate as antidote to MgSO4 toxicity 
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If MgSO4 is administered, providers should monitor patients for clinical evidence of toxicity, which may 
present as depressed respiratory rate, loss of tendon reflex, or decreased urine output, either in isolation 
or in any combination of all three. Less than 11 percent of the healthcare providers surveyed mentioned 
the three potential symptoms to monitor MgSO4 toxicity. As expected, medical officers are more likely to 
know how to monitor MgSO4 and which drug is used to treat it. Two-thirds of medical practitioners did not 
know how to monitor for toxicity or know the antidote (Table 9). 
 
TABLE 9    Knowledge of monitoring MgSO4 toxicity 
 Ways to monitor 
MgSO4 toxicity 
 
What drug is used for treating 
MgSO4 toxicity? 
 % Correct 
response 
p-value n=379 
% Correct 
response 
p-value n=379 
Type of provider        
Medical practitioner  31.4 
0.000 
35 57.1 
0.000 
35 
Nurse/Midwife  10.0 200 38.0 200 
CHEW. CHO & Others  7.6 144 9.0 144 
Type of facility        
Tertiary  18.8 
0.046 
80 36.3 0.000 80 
Secondary  9.7 124 46.0  124 
Primary  8.6 175 13.1  175 
Years working in present unit/ward        
≤1 years  14.0 
0.103 
93 34.4 0.007 93 
>1—5 years  13.9 158 26.6  158 
>5 years  5.6 89 28.1  89 
No response  5.1 39 25.6  39 
Received any training on maternal health, FP or child health care   
Yes  13.9 
0.072 
194 33.5 0.008 194 
No  8.1 185 23.8  185 
 
 
During this landscape analysis, we assessed facilities’ readiness to effectively manage PE/E by examining 
their guidelines, essential tools, and commodities, if they keep MgSO4 in stock, and the concentration of 
MgSO4 used. Figure 9 shows how facilities in the seven study states generally obtain MgSO4. Overall, 39 
percent of facilities asked women with PE/E (or their families) to purchase MgSO4 from outside sources, as 
the drug is not stored routinely at the facilities. However, it may take time to obtain the drug, depending on 
affordability and proximity to drug stores that stock it. This delay worsens the outcomes for women and 
their unborn babies. The tendency to ask PE/E patients or their families to purchase MgSO4 was highest in 
Katsina and Kogi states, but not practiced in Ebonyi. 
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FIGURE 9    How facilities obtain MgSO4 
 
 
 
Overall 20 percent of facilities do not use MgSO4, and only 42 percent reported always using MgSO4 as an 
anticonvulsant (Figure 10). In Ebonyi and Cross River states, 70 percent and 55 percent respectively, of 
facilities do not use MgSO4 to prevent and treat convulsions. 
 
FIGURE 10   MgSO4 use for treating pre-eclampsia or eclampsia 
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Figure 11 shows the distribution of ‘20%’ and ‘50%’ MgSO4 concentrations among the seven study states. 
Overall, 66 percent of facilities used 50% solution and only 20% of the facilities use 20% solution. Bauchi, 
Katsina, Kogi, and Sokoto States use the 50% strength, while Ebonyi State uses the 20% solution. There is 
increasing support for a 50% concentration among the public sector and donors’ procurement mechanisms 
due to the simple preparation required for its administration. Therefore, it is not surprising to find that the 
50% solution dominates the public sector, while both concentrations are found with similar frequencies in 
states where private procurement is common, such as Ebonyi State. 
 
FIGURE 11    Concentration (%) of MgSO4 used in facilities  
 
 
 
 
  
33
10
25
12
14
33
40
20
50
90
75
82
43
17
60
66
17
0
0
6
43
50
0
14
0 20 40 60 80 100
Kogi
Katsina
Sokoto
Bauchi
Ondo
Ebonyi
Cross River
All
%
20% Solution 50% Solution Not avaliable
 24 
 
Client Experiences 
Researchers conducted client exit interviews after the ANC consultations to determine pregnant women’s 
perceptions on the quality of care they received and their understanding of the services received. The 
disaggregated percentages in Table 9 show that while 91 percent of women had their blood pressure 
measured, when probed further about the services received, only 31 percent of women reported that their 
healthcare provider informed them of their BP measurement and 32 percent received an explanation of 
the meaning of high blood pressure. Similarly, while two-thirds of women had their protein checked for 
urine, a mere 19 percent were given an explanation about why protein in the urine is important to measure 
(data not shown in the table). 
 
TABLE 9   Proportion of pregnant women receiving specific services and information 
during ANC consultations by state 
 
State Took 
weight 
BP 
check 
Performed 
abdominal 
examination 
Checked 
for 
anemia 
Listened 
to  
baby’s 
heart 
beat 
Checked 
urine for 
protein 
and 
sugar 
Talked 
with client 
about the 
progress 
of your 
pregnancy 
Gave 
client 
chance 
to ask 
questions  
Number of 
women 
interviewed  
 % % % % % % % % n  
Cross 
River  100 100 93 40 93 87 87 87 15 
Ebonyi  100 100 80 50 80 40 50 80 10 
Ondo  77 91 68 41 68 59 68 73 22 
Kogi  87 80 67 73 67 67 67 60 15 
Sokoto 73 100 95 22 78 60 68 60 37 
Katsina 50 63 25 38 25 63 25 25 8 
Bauchi  89 89 93 46 93 82 86 89 28 
Total  82 92 82 41 77 67 70 70 135 
 
Regardless of demographic and socio-economic status, a number of clients (a third overall) said the 
providers did not discuss the progress of the pregnancy or give a chance for them to ask questions. This 
was least likely to happen in Katsina followed by Ondo state. None of the states performed well in all areas. 
The two weakest components were checking for anemia and checking urine for protein and sugar.  
 
Table 10 presents composite responses of the eight ANC services provided during the current and any ANC 
consultation by socio economic/demographic status. Overall, less than one-third of women interviewed 
received all of the ANC services in this visit and one-sixth received all of the services at any ANC visit. 
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TABLE 10 Proportion of clients receiving all eight components of ANC by social 
demographic status (composite score) 
 
n 
Yes 
% 
p-value 
Yes 
% 
p-value 
  Proportion of clients who 
received all 8 ANC 
components during this visit 
Proportion of clients who received 
all services listed during any ANC 
visit 
Age (years)      
≤24 41 24.4 
0.499 
17.1 0.767 
≥25 93 30.1 15.1  
Education       
None  29 20.7 
0.546 
13.8 0.791 
Primary  12 33.3 8.3  
Secondary  41 24.4 19.5  
Higher  53 34.0 15.1  
Marital status       
Married  130 28.5 
1.000* 
13.8 0.027* 
Formerly married  5 20.0 60.0  
Socio-economic status       
Low  50 30.0 
0.792 
18.0 0.088 
Middle  63 25.4 19.0  
High  22 31.8 0.0  
Religion       
Christianity  60 26.7 
0.732 
16.7 0.750 
Islam  75 29.3 14.7  
Total  135 28.1  15.6  
*Fischer Exact Test 
 
Cutting across women of all demographic and socio-economic status, and despite the large gap in the 
content and quality of ANC they received, most women said they would go back to the same facilities for 
future care and expressed satisfaction with the care they received. Only 12 percent of women said that they 
would not return to the same health facility; the reasons cited for not returning were that the facility was 
too far, a lack of money to pay for services, a lack of supplies/medicine at facility, not enough providers at 
the facility, providers were unfriendly, and poor services at the facility. 
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COMMUNITY-LEVEL PERCEPTIONS 
Qualitative interviews were conducted with PE/E survivors, community stakeholders and families affected 
by PE/E on their understanding of PE/E and care seeking pathways.  
 
All groups (men and women; rural and urban areas) described similar health challenges for pregnant 
women, these include malaria, typhoid, cough, stomach ache, and high blood pressure. There is some 
confusion regarding the diagnosis of pre-eclampsia and malaria. Headache during pregnancy is more often 
assumed to be a symptom of malaria. The signs and symptoms associated with PE/E are sometimes 
attributed to excessive drinking of liquids and over exposure to cold weather. 
 
Respondents also had similar perceptions as to the cause of high blood pressure. Some people believe evil 
spirits (e.g., demons, witches, and ancestors) cause seizures. Rural community men perceive that high 
blood pressure is caused  by engaging in ‘strenuous’ or ‘tedious’ activities and not eating a balanced diet. 
‘Over thinking’ and anxiety were also deemed to be causes of high blood pressure in pregnancy.  
 
“First pregnancies always lead to high blood pressure because some women listen to 
stories of pregnancy worries.” Male FGD 
 
Misconceptions, belief in myths, and mistrust between communities and health providers negatively 
influence care seeking behaviors for PE/E. Reasons given why women do not seek care at facilities arefear 
of death, lack of facilities, lack of qualified providers, and disrespectful providers. Overall, men appear to 
encourage their wives to go to ANC and to hospital to deliver, but some mothers-in-law favor herbalists and 
prayer as the first line of ‘health seeking’ before going to the hospital. Participants described using herbs, 
incisions, and prayers. Two conflicting quotes are outlined below: 
 
“In our community, people think doctors can’t solve the problem, so they prefer the 
herbalist.” Community stakeholder 
 
“It is better to go to hospital than native because if the problem does not go, the person will 
die.” Male FGD 
 
When asked what interventions might improve care for pregnant women with PE/E, suggestions included 
house to house teaching, community seminars and public enlightenment through radio, fliers, and church 
notifications. 
EXPERIENCES OF SURVIVORS OF PE/E 
Interviews with survivors documented their care-seeking pathways, including their experience with PE/E, 
the availability and accessibility of essential services and commodities, the outcome of the pregnancy for 
the mother and her child. The women interviewed were similar in age, age at marriage, age at first 
pregnancy, and education levels. Majority of respondents attend ANC very late; or at the tail end of the 
second trimester except in Kogi State where the respondents reported attending ANC during the first 
trimester or early second trimester. However, more than half started ANC when they begin to notice some 
pregnancy-related problems like swollen legs or face or a severe headache. Most women attended public 
health facilities. Responses also show that during ANC, BP is mostly measured and urine is tested but 
results are not often made known except when a complication is about to occur. Information regarding 
possible pregnancy-related problems is not properly communicated during ANC consultations. 
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In all instances, MgSO4 was not stocked at the health facilities, and so the women purchased the drug from 
external sources such as pharmacies and drug shops.  
 
Case study 
A 40-year-old woman with a postgraduate degree was married at age 29 and became pregnant at age 33. 
After three pregnancies, she has two living children. She lives within twenty minutes of a health facility. 
During the second pregnancy, she booked herself at a nurse-attended health facility and attended 12 ANC 
visits. She developed eclampsia and received MgSO4, but eventually delivered a stillborn baby. She 
purchased the MgSO4 from the outside pharmacy shop, and said the drug was easily available and 
affordable.  
 
“I lost the baby. It took a while before my blood pressure eventually normalized. The same 
headache was there, discomfort, and swelling of the legs was there for quite a long time 
after the baby died.” -Survivor 
 
Younger women were also interviewed. They differed from the women discussed above not only in age, but 
also in education level and socio-economic status.  
 
“I am 17 years old, and I was married two years ago. This is my first pregnancy and it is 
nine months. I never attend ANC before, but I came to the hospital when I had a severe 
headache for over two weeks, I became dizzy and fell down. I went to a hospital…I did not 
know what happened, but later the doctor told me that my BP was 250/150… I am OK now, 
but lost my baby.” - Survivor 
 
“I only come to the hospital when am critically ill. I delivered twins, but I lost the first one. 
Drugs are very expensive, and my husband cannot afford to buy them and my relatives 
don’t have anything. They said I need more blood but I did not get it yet. I am very weak, 
and have no food and no money to buy food.” - Survivor 
 
“Or you are seeking for a particular sex, every time, day and night, you will be thinking ‘I am 
going to have male child or female child,’ such a thing can lead to high blood pressure.” –
Survivor 
  
 28 
 
Discussion 
This landscape analysis set out to understand the existing and ongoing research, as well as the policy and 
programmatic support for PE/E in Nigeria. It also aimed to analyze the gaps in facilities’ and providers’ 
capacity to prevent, detect, and manage PE/E; assess community awareness, beliefs, and experiences 
around PE/E; and determine the gaps and priority areas for research and programs for improving access 
to prevention and treatment of PE/E.  
 
There are national policies that enable task shifting of essential MCH interventions from nurses/midwives 
to CHEWs/CHOs, specifically empowering CHEWs to detect and administer a loading of MgSO4 to women 
with PE/E (among other pregnancy complications) before referral (Federal Ministry of Health, 2014), but, 
few policy makers at state level were aware of these national policies. For successful implementation and 
scale up, all existing policy documents at the national and state levels should be communicated down to 
local stakeholders for proper utilization. More than 90 percent of health providers surveyed were 
nurses/midwives or CHEWs/CHOs working at primary and secondary facilities and many at PHC facilities 
are unaware of policy changes that empower them to administer a loading dose of MgSO4 before referring 
patients.  
 
Despite the evidence that low-dose aspirin, started between 12 and 20 weeks gestation in women with 
known risk factors for pre-eclampsia, significantly reduces the incidence of PE (World Health Organization, 
2011), it appears that this preventative strategy has not yet been adopted by Nigeria. It is therefore not 
surprising that more than four-fifths of healthcare providers do not routinely assess for risk factors, let alone 
deploy effective preventive measures. While more health providers than expected were aware of the 
prophylactic role of aspirin in PE (21% overall, and 33% in Ebonyi), the actual administration is 
disproportionately low. Additionally, few states are offering calcium to women as prophylaxis.  
 
Similarly, little is being done to manage hypertension in pregnant women, as most providers do not give 
anti-hypertensives for women with hypertensive disorders during pregnancy. This is possibly a result of their 
inability to classify, and determine the severity of the hypertensive disorders in pregnancy. In Nigeria, anti-
hypertensives for the treatment of mild to moderate hypertension (aldomet and nifedipine) and severe 
hypertension (hydralazine) are cheap and easily obtainable. They should be routinely available in maternity 
emergency trays in most facilities, and if not, can be obtained from external sources. Therefore, it is 
imperative that future interventions targeting health providers, especially at primary and secondary 
facilities, include training on suitable anti-hypertensives for pregnant women with PE/E. 
 
For effective management of PE/E, health providers also need training and mentoring on how to use MgSO4. 
With few providers understanding the loading and maintenance doses of MgSO4 for managing PE/E, it is 
not surprising that these pregnancy complications account for more maternal deaths than any other cause, 
including postpartum hemorrhage (Oladapo 2015).  
 
While ensuring that healthcare providers are adequately trained to administer MgSO4 at the right time and 
with the proper doses, they also need to know the warning signs for MgSO4 toxicity and the proven antidote, 
calcium gluconate. Currently, this knowledge is lacking, as 64 percent of providers were unaware of 
possible toxicity and how to treat it.  
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It is common for maternal health commodities to be unavailable when needed. For example, up to 39 
percent of facilities surveyed don’t keep MgSO4 on site but ask patients to purchase the drug from outside 
sources. In most cases, patients cannot afford the drugs or are not close enough to health facilities. 
Similarly, the necessary guidelines, job aids, working tools, and equipment are lacking in many facilities. 
Policy makers and program managers should make sure that facilities are supported with the required tools 
and equipment, as well as guidelines in order to help them manage PE/E and improve the overall quality of 
care. This includes providers assessing medical history or educating women on signs and symptoms of 
pregnancy-related complications. 
 
Care seeking pathways by women suffering from PE/E are similar to other maternal complications – 
especially in areas where women have little agency to make decisions about seeking care and having to 
rely on other people to make those decisions. Challenges around the recognition of PE exist due to the 
similar symptoms to malaria (headache/blurred vision) that may delay women seeking care. These 
persistent community misconceptions around the causes and outcomes of PE/E constitute threats to the 
prevention, early detection, and treatment of PE/E. Despite some awareness creation activities and 
community mobilization efforts, many community members still ascribe spiritual and social factors as 
causes for PE/E. 
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Conclusion and recommendations 
In order to improve the health outcomes for women with PE/E in Nigeria, the following cross-cutting activties 
are recommended. 
CROSS-CUTTING RECOMMENDATIONS 
 
1. Hold meetings to discuss the current policy, strategy and guidelines on prevention and detection of 
PE/E. The national reproductive health coordinating committee convene a task force to work on 
this issue led by joint chairpersons from SOGON, FMoH and the Nursing/Midwifery Association. This 
taskforce would also look into streamlining procurement of MgSO4 and other maternal health 
commodities and drugs (anti-hypertensives, oxytocin, antibiotics, others). 
  
2. Work with federal and state governments to ensure that quality MgSO4 is procured systematically.  
 
3. National ‘task force’ to review evidence on aspirin/calcium prophylaxis, including the cost of 
introducing /ensuring consistent supply of aspirin and or calcium supplements. If task force agrees 
to go forward with prophylaxis approach, guidelines need to be updated prior to stepwise 
introduction of aspirin and calcium prophylaxis. 
 
4. Emphasis should be placed on primary and secondary facilities that treat more than 90% of 
pregnant women. Within these platforms, nurses, midwives, CHEWs, and CHOs need training and 
mentoring programs. All maternity care providers at the primary and secondary facilities should 
know how to triage women at risk of developing PE. 
 
5. Improve the quality of ANC services; providers should conduct routine assessments (specifically BP 
measurement and urine testing for proteinuria) and advise pregnant women of key danger signs 
during ANC consultations.  
 
6. Provide training on the management of premature babies that may inadvertently arise as an 
unwanted consequence of PE/E treatment. 
 
7. Engage with local communities to dispel misperceptions around the risks and consequences of 
PE/E is critical for effective interventions.  
 
8. Communicate national maternal health policies to health providers at primary and secondary 
facilities.  
 
9. Conduct implementation research to guide the development of highly-effective, low-cost 
interventions for the prevention and management of PE/E at different levels of the health system: 
a. Test feasibility of adding anti-hypertensives at PHC level; 
b. Improve quality of ANC; and 
c. Community awareness strategies – media, women’s groups, champions, among others. 
 
10. Dissemination of findings at state level through research updates for each individual state and 
meetings. 
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